Sahoo Ajaya Kumar, Gupta Dhyuti, Dhaneria Suryaprakash, Thangaraju Pugazhenthan, Singh Alok
Department of Pharmacology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
J Res Pharm Pract. 2020 Oct 8;9(3):146-150. doi: 10.4103/jrpp.JRPP_20_29. eCollection 2020 Jul-Sep.
Drug utilization studies provide information regarding the drug usage pattern in hospital settings, which can be used to promote cost-efficient uses of drugs. The present observational retrospective study was conducted to evaluate the drug utilization pattern in a tertiary care center in India and create a baseline consumption data for the drugs, simultaneously identifying targets for improving drug prescribing pattern.
The current retrospective cross-sectional study was conducted at All India Institute of Medical Sciences Raipur, wherein the 217 medical records of different departments for August 2019 were chosen randomly (using systematic random sampling) for evaluation. The information was extracted from medical records regarding the basic demographic details, drug strength, route, and total amount, and eventually, the World Health Organization (WHO) core indicators were estimated. Drug utilization data were assessed using the WHO Anatomical Therapeutic Chemical/Defined Daily Dose (ATC-DDD) methodology. Potential drug-drug interactions were also analyzed.
Most of the records analyzed were of male patients (56.2%). Drugs prescribed by their generic name were 50%. Prescriptions containing injection and antimicrobials were 68.1% and 83.6%, respectively. 49.3% of the patients had received a fixed-dose combination, and 60.9% of drugs belonged to the National List of Essential Medicines 2015. A total of 15 potential drug interactions were found.
Calculated prescribed daily dose of most of the antimicrobials and other groups of drugs was close to the WHO-DDD. Trade name prescription and polypharmacy were very common. Antibiotics accounted for the majority of drug costs.
药物利用研究提供了有关医院环境中药物使用模式的信息,可用于促进药物的成本效益使用。本观察性回顾性研究旨在评估印度一家三级医疗中心的药物利用模式,创建药物的基线消费数据,同时确定改善药物处方模式的目标。
当前的回顾性横断面研究在赖布尔全印度医学科学研究所进行,其中随机选择(采用系统随机抽样)2019年8月不同科室的217份病历进行评估。从病历中提取有关基本人口统计学细节、药物强度、给药途径和总量的信息,最终估算世界卫生组织(WHO)核心指标。使用WHO解剖治疗化学/限定日剂量(ATC-DDD)方法评估药物利用数据。还分析了潜在的药物相互作用。
分析的大多数记录是男性患者的(56.2%)。使用通用名开具的药物占50%。含注射剂和抗菌药物的处方分别占68.1%和83.6%。49.3%的患者接受了固定剂量复方制剂,60.9%的药物属于《2015年国家基本药物目录》。共发现15种潜在的药物相互作用。
大多数抗菌药物和其他药物组的计算规定日剂量接近WHO-DDD。商品名处方和多药联用非常普遍。抗生素占药物成本的大部分。